How Did COVID-19 Impact the Antimicrobial Consumption and Bacterial Resistance Profiles in Brazil?
Antibiotics · 28.08.2023 · 12 (9) · 1374
DOI: 10.3390/antibiotics12091374 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antibiotics, online erschienen am 28.08.2023. Verfasst von Natália Cassago Marcos Massarine und 7 weiteren Autor:innen. Beteiligte Einrichtung: Health Sciences Research Laboratory, Universidade Federal da Grande Dourados, Dourados 79825-070, MS, Brazil. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), Fundação de Apoio ao Desenvolvimento do Ensino, Ciência e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT), Universidade Federal da Grande Dourados (UFGD).
Abstract (Originalsprache)
The indiscriminate use of antibiotics has favored the selective pressure of multidrug resistance among microorganisms. This research evaluated the pattern of antibiotic prescriptions among the Brazilian population between January 2018 and December 2021. Additionally, the study sought to analyze the incidence rates of central line-associated bloodstream infection (CLABSI) and examine the profiles of antibiotic resistance. We assessed the hospital and community antimicrobial consumption from the National Health Surveillance Agency Database and correlated it to microorganisms. The consumption of antimicrobials in the hospital environment increased by 26% in 2021, highlighting polymyxin B, which increased by 204%. In 2021, 244,266 cases of CLABSI were reported, indicating a nosocomial infection rate of 7.9%. The rate of resistance to polymyxin B was higher in Pseudomonas aeruginosa (1400%) and Klebsiella pneumoniae (514%). Azithromycin emerged as the predominant antibiotic utilized within the community setting, accounting for 24% of the overall consumption. Pearson’s correlation analysis revealed a significant and positive correlation (r = 0.71) between the elevated usage of azithromycin and the incidence of COVID-19. Our results indicate an increase in antimicrobial consumption during the COVID-19 pandemic and reinforce the fact that the misuse of antimicrobials may lead to an expansion in antimicrobial resistance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Health Sciences Research Laboratory, Universidade Federal da Grande Dourados, Dourados 79825-070, MS, Brazil.
ORCID-Profile: Túlio Máximo Salomé, Izadora Faccin, Luana Rossato, Simone Simionatto
Förderung
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
- Fundação de Apoio ao Desenvolvimento do Ensino, Ciência e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT)
- Universidade Federal da Grande Dourados (UFGD)
Zitieren
APA
Massarine, N. C. M., de Souza, G. H. A., Nunes, I. B., Salomé, T. M., Barbosa, M. D. S., Faccin, I., Rossato, L., & Simionatto, S. (2023). How Did COVID-19 Impact the Antimicrobial Consumption and Bacterial Resistance Profiles in Brazil?. Antibiotics, 12(9), 1374. https://doi.org/10.3390/antibiotics12091374
Vancouver
Massarine NCM, de Souza GHA, Nunes IB, Salomé TM, Barbosa MDS, Faccin I, et al. How Did COVID-19 Impact the Antimicrobial Consumption and Bacterial Resistance Profiles in Brazil?. Antibiotics. 2023;12(9):1374. doi:10.3390/antibiotics12091374
BibTeX
@article{Massarine2023,
author = {Massarine, Natália Cassago Marcos and de Souza, Gleyce Hellen de Almeida and Nunes, Isadora Batista and Salomé, Túlio Máximo and Barbosa, Marcelo Dos Santos and Faccin, Izadora and Rossato, Luana and Simionatto, Simone},
title = {How Did COVID-19 Impact the Antimicrobial Consumption and Bacterial Resistance Profiles in Brazil?},
journal = {Antibiotics},
year = {2023},
volume = {12},
number = {9},
pages = {1374},
doi = {10.3390/antibiotics12091374}
}
EUVIMED